Freyr has announced been chosen for strategic regulatory eCTD submission and publishing services by a US based, Fast growing Clinical Research Company.

As part of the contract, Freyr will provide eCTD submissions and publishing services to the client leveraging its deep capabilities and skills to drive improvements in the planning and delivery of critical submissions, and to generate process efficiencies.

Being chosen for the eCTD submissions, Sudheer Sagar, VP Operations at Freyr said, “Freyr offers a comprehensive suite of regulatory submission services that leverages the integrated regulatory intelligence platform to significantly improve the regulatory function strategy, processes and operations to accelerate superior submissions and reduce operational costs.”